The Lancet, considered one of the leading medical journals in the world, profiles Fenway’s Kenneth H. Mayer, MD in their November 2 issue as a “global leader in HIV prevention.” The profile covers Dr. Mayer’s HIV/AIDS and public health research career from the early days of the epidemic through the breakthrough iPrex study which demonstrated the effectiveness of PrEP for HIV prevention and his current work enhancing and adapting PrEP using new technologies.
“Ken brings a rare combination of head and heart to his research work. He has broad and deep knowledge of clinical medicine, infectious diseases, clinical trial research, prevention, and risk behaviours, yet remains unpretentious, highly collegial, and profoundly committed to both HIV research and to LGBT health”, Chris Beyrer of the Johns Hopkins Bloomberg School of Public Health told The Lancet.
You can read The Lancet’s profile of Dr. Mayer in its entirety here (PDF).
Dr. Mayer is the Director of Medical Research and Co-Chair of The Fenway Institute at Fenway Health. He has been involved in HIV/AIDS research since the earliest days of the epidemic, diagnosing some of the first HIV cases in New England. He also serves as Professor of Medicine at Harvard Medical School; Professor, Department of Global Health and Population at the Harvard School of Public Health; Director of HIV Prevention Research and Attending Physician at Beth Israel Deaconess Medical Center; and Adjunct Professor of Medicine and Community Health at Brown University.
The Lancet’s prestigious heritage as one of the world’s leading medical journals continues to inspire authors and editors today as they strive for medical excellence in all that they publish. When Thomas Wakley founded The Lancet in 1823, he announced “A lancet can be an arched window to let in the light or it can be a sharp surgical instrument to cut out the dross and I intend to use it in both senses”. This philosophy remains at the heart of the journal today. The Lancet has been, first and foremost, a reformist medical newspaper known for its campaigns, for example, their focus on child survival in recent years. Thomas Wakley and his successors aimed to combine publication of the best medical science in the world with a zeal to counter the forces that undermine the values of medicine, be they political, social, or commercial. More online.